# A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma

> **NCT00855517** · PHASE2 · WITHDRAWN · sponsor: **Mati Therapeutics Inc.**

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Latanoprost-PPDS

## Key facts

- **NCT ID:** NCT00855517
- **Lead sponsor:** Mati Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-03
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor's decision
- **Last updated:** 2013-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00855517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00855517, "A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00855517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*